QUEST DIAGNOSTICS INC
For the period ended Dec 31, 2024. Filed Feb 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 20, 2025
DGX$259.67+1.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
(in millions, except per share data)
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Net revenues | $9,872 | $9,252 | $9,883 |
| Operating costs and expenses and other operating income: | |||
| Cost of services | 6,628 | 6,199 | 6,450 |
| Selling, general and administrative | 1,770 | 1,642 | 1,874 |
| Amortization of intangible assets | 127 | 108 | 120 |
| Other operating expense, net | 1 | 41 | 11 |
| Total operating costs and expenses, net | 8,526 | 7,990 | 8,455 |
| Operating income | 1,346 | 1,262 | 1,428 |
| Other income (expense): | |||
| Interest expense, net | (201) | (152) | (138) |
| Other income (expense), net | 30 | 20 | (55) |
| Total non-operating expense, net | (171) | (132) | (193) |
| Income before income taxes and equity in earnings of equity method investees | 1,175 | 1,130 | 1,235 |
| Income tax expense | (273) | (248) | (264) |
| Equity in earnings of equity method investees, net of taxes | 19 | 26 | 44 |
| Net income | 921 | 908 | 1,015 |
| Less: Net income attributable to noncontrolling interests | 50 | 54 | 69 |
| Net income attributable to Quest Diagnostics | $871 | $854 | $946 |
| Earnings per share attributable to Quest Diagnostics’ common stockholders: | |||
| Basic | $7.78 | $7.59 | $8.10 |
| Diluted | $7.69 | $7.49 | $7.97 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.